Ipamorelin + Mod GRF(1-29)

this combination is used in research for its ability to model coordinated GH regulation using two mechanistically distinct peptides. By combining a selective growth hormone secretagogue with a stabilised GHRH analogue, this blend enables detailed assessment of timing, amplitude, and pathway specificity during GH-pulse stimulation studies.

Common research applications include:

• Examining pituitary GH secretion under dual-peptide stimulation

• Mapping receptor-driven GH-axis signalling cascades

• Studying synergistic endocrine pathway activation

• Comparing single-compound versus combination effects

The Ipamorelin + Mod GRF(1-29) peptide blend supports reproducible mechanistic work by offering consistent performance and controlled dosing characteristics. Because each peptide contributes defined signalling behaviour, the blend assists researchers in generating clear, interpretable data across repeated trials.

This blend is supplied as a high-purity laboratory reagent for use exclusively by qualified scientific professionals. It is not approved for human or veterinary administration, therapeutic use, clinical application, or diagnostic intent. All handling must follow appropriate institutional safety procedures and regulatory requirements for investigational endocrine materials.

For research use only. Not for human consumption.